106 related articles for article (PubMed ID: 23017142)
1. Phenotypic plasticity of MDSC in cancers.
Manjili MH
Immunol Invest; 2012; 41(6-7):711-21. PubMed ID: 23017142
[TBL] [Abstract][Full Text] [Related]
2. Highlights on molecular mechanisms of MDSC-mediated immune suppression: paving the way for new working hypotheses.
Solito S; Pinton L; Damuzzo V; Mandruzzato S
Immunol Invest; 2012; 41(6-7):722-37. PubMed ID: 23017143
[TBL] [Abstract][Full Text] [Related]
3. Resiquimod, a TLR7/8 agonist, promotes differentiation of myeloid-derived suppressor cells into macrophages and dendritic cells.
Lee M; Park CS; Lee YR; Im SA; Song S; Lee CK
Arch Pharm Res; 2014; 37(9):1234-40. PubMed ID: 24748512
[TBL] [Abstract][Full Text] [Related]
4. Negative regulation of myeloid-derived suppressor cells in cancer.
Qu P; Boelte KC; Lin PC
Immunol Invest; 2012; 41(6-7):562-80. PubMed ID: 23017135
[TBL] [Abstract][Full Text] [Related]
5. Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function.
Hu CE; Gan J; Zhang RD; Cheng YR; Huang GJ
Scand J Gastroenterol; 2011 Feb; 46(2):156-64. PubMed ID: 20822377
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-derived suppressor cell heterogeneity and subset definition.
Peranzoni E; Zilio S; Marigo I; Dolcetti L; Zanovello P; Mandruzzato S; Bronte V
Curr Opin Immunol; 2010 Apr; 22(2):238-44. PubMed ID: 20171075
[TBL] [Abstract][Full Text] [Related]
7. Tumor regulation of myeloid-derived suppressor cell proliferation and trafficking.
Younos IH; Dafferner AJ; Gulen D; Britton HC; Talmadge JE
Int Immunopharmacol; 2012 Jul; 13(3):245-56. PubMed ID: 22609473
[TBL] [Abstract][Full Text] [Related]
8. Myeloid derived suppressor cells in transplantation.
Lees JR; Azimzadeh AM; Bromberg JS
Curr Opin Immunol; 2011 Oct; 23(5):692-7. PubMed ID: 21802931
[TBL] [Abstract][Full Text] [Related]
9. Tumor-host immune interactions and dendritic cell dysfunction.
Yang L; Carbone DP
Adv Cancer Res; 2004; 92():13-27. PubMed ID: 15530555
[TBL] [Abstract][Full Text] [Related]
10. Myeloid derived suppressor cells and their role in diseases.
Kong YY; Fuchsberger M; Xiang SD; Apostolopoulos V; Plebanski M
Curr Med Chem; 2013; 20(11):1437-44. PubMed ID: 23409714
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell subtypes and in vitro generation of dendritic cells.
Jacobs B; Wuttke M; Papewalis C; Seissler J; Schott M
Horm Metab Res; 2008 Feb; 40(2):99-107. PubMed ID: 18283627
[TBL] [Abstract][Full Text] [Related]
12. Functional changes in myeloid-derived suppressor cells (MDSCs) during tumor growth: FKBP51 contributes to the regulation of the immunosuppressive function of MDSCs.
Kim YS; Kim YJ; Lee JM; Kim EK; Park YJ; Choe SK; Ko HJ; Kang CY
J Immunol; 2012 May; 188(9):4226-34. PubMed ID: 22474024
[TBL] [Abstract][Full Text] [Related]
13. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.
Greifenberg V; Ribechini E; Rössner S; Lutz MB
Eur J Immunol; 2009 Oct; 39(10):2865-76. PubMed ID: 19637228
[TBL] [Abstract][Full Text] [Related]
14. Immune suppression: the hallmark of myeloid derived suppressor cells.
Haile LA; Greten TF; Korangy F
Immunol Invest; 2012; 41(6-7):581-94. PubMed ID: 23017136
[TBL] [Abstract][Full Text] [Related]
15. Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties.
Brandau S; Trellakis S; Bruderek K; Schmaltz D; Steller G; Elian M; Suttmann H; Schenck M; Welling J; Zabel P; Lang S
J Leukoc Biol; 2011 Feb; 89(2):311-7. PubMed ID: 21106641
[TBL] [Abstract][Full Text] [Related]
16. Antigen specificity of immune suppression by myeloid-derived suppressor cells.
Solito S; Bronte V; Mandruzzato S
J Leukoc Biol; 2011 Jul; 90(1):31-6. PubMed ID: 21486906
[TBL] [Abstract][Full Text] [Related]
17. The current immune function of hepatic dendritic cells.
Hsu W; Shu SA; Gershwin E; Lian ZX
Cell Mol Immunol; 2007 Oct; 4(5):321-8. PubMed ID: 17976311
[TBL] [Abstract][Full Text] [Related]
18. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
19. Guest editorial.
Abrams S
Immunol Invest; 2012; 41(6-7):555-61. PubMed ID: 23017134
[No Abstract] [Full Text] [Related]
20. Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice.
Saha A; Chatterjee SK; Foon KA; Primus FJ; Sreedharan S; Mohanty K; Bhattacharya-Chatterjee M
Cancer Res; 2004 Jul; 64(14):4995-5003. PubMed ID: 15256474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
